Encryption Standards for Medical Devices 2026
Post Summary
Medical device encryption is now mandatory. Starting in 2026, the HIPAA Security Rule requires AES-256 for stored data and TLS 1.2 or higher for transmitted data. This change aims to protect electronic protected health information (ePHI) as cyberattacks on healthcare systems rise. Key updates include:
- Encryption at Rest: AES-256 for databases, backups, and storage.
- Encryption in Transit: TLS 1.2+ (TLS 1.3 preferred) for secure communications.
- Faster Incident Reporting: Business associates must report breaches within 24 hours.
- FDA Requirements: Secure Product Development Frameworks (SPDF) and Software Bill of Materials (SBOM) are now essential for compliance.
- Legacy Devices: Older systems must use compensating controls like network segmentation.
With the Internet of Medical Things (IoMT) market projected to reach $650 billion by 2030, these regulations ensure data security and patient safety. Healthcare organizations must act quickly to update systems, manage encryption keys, and address gaps in compliance.
Medical Device Cybersecurity 101: What You Need to Know to Get to Market
sbb-itb-535baee
Required Encryption Standards for Medical Devices 2026
2026 Medical Device Encryption Standards Requirements Overview
The 2026 updates bring a major change to encryption rules, making encryption a mandatory safeguard for all electronic protected health information (ePHI) instead of an "addressable" option. This ensures consistent protection across the board for healthcare data [3]. These updates create clear technical standards that every medical device manufacturer and healthcare provider must follow.
At the core of these requirements are two encryption standards: AES-256 for data at rest and TLS 1.2 or higher for data in transit. These are not optional - they are required measures to protect ePHI. Here's a quick breakdown of the key requirements:
| Requirement | Standard | Applies To | Deadline |
|---|---|---|---|
| Encryption at rest | AES-256 (NIST-approved) | Databases, file systems, backups, removable media | 2026 |
| Encryption in transit | TLS 1.2+ (TLS 1.3 recommended) | Networks, APIs, email | 2026 |
| Field-level encryption | Application-layer encryption | Names, SSNs, MRNs, diagnoses, prescription data | 2026 |
| Key management | NIST SP 800-57 compliant | All encryption keys protecting ePHI | 2026 |
| Audit logging | Tamper-evident logs | All access to encrypted ePHI | 2026 |
Over the last five years, many healthcare data breaches were caused by unencrypted data - whether from lost laptops, unsecured USB drives, or poorly configured cloud storage [3]. These updated standards aim to close those gaps by requiring encryption at every point where ePHI is stored or transmitted. Below, we’ll dive into the specific protocols for both stored and transmitted data.
AES-256 for Stored Data
AES-256 is now the official standard for encrypting ePHI at rest, aligning with updates to the HIPAA Security Rule. While quantum computing poses a theoretical risk to encryption, AES-256 remains highly secure for long-term data protection [3]. This is critical, as HIPAA mandates a 6-year record retention period, and some states require even longer retention - exceeding 10 years in certain cases [3].
To comply, organizations must implement AES-256 across various layers, including:
- Databases: Transparent Data Encryption (TDE) tools.
- Storage Volumes: Solutions like LUKS or BitLocker.
- Cloud Storage: Services such as S3 SSE-KMS.
Additionally, the new rules require field-level encryption at the application layer. This ensures sensitive data fields - like Social Security numbers, medical record numbers, and diagnoses - are protected even if a database is breached through methods like SQL injection or insider threats. With these measures in place, stored ePHI is safeguarded, but securing data in transit is equally important.
TLS 1.3 for Transmitted Data
While AES-256 secures data at rest, strong protocols are essential to protect data in motion. The updated standards require TLS 1.2 or higher for all transmitted ePHI, with a preference for TLS 1.3 due to its advanced security features. TLS 1.3 offers a streamlined handshake process, eliminates outdated cipher suites, and includes quantum-resistant key exchanges like Kyber-1024 [3]. This makes it better equipped to defend against threats like man-in-the-middle attacks and "Harvest Now, Decrypt Later" schemes, where attackers collect encrypted data today to decrypt it in the future using more advanced technology [3].
To meet these requirements, organizations should:
- Enable HTTP Strict Transport Security (HSTS) to enforce secure connections.
- Audit internal service-to-service communication to ensure all traffic is encrypted.
For older medical devices that cannot support TLS 1.2 or higher, alternative solutions such as network segmentation or gateway mechanisms may be necessary to maintain compliance without disrupting device functionality.
These encryption standards set a robust framework for protecting ePHI, addressing vulnerabilities that have plagued the healthcare industry for years. By implementing these measures, organizations can significantly reduce the risk of breaches while meeting the demands of the 2026 regulations.
Meeting Regulatory Requirements and Implementation Standards
Starting in 2026, cybersecurity is considered a core quality issue in regulatory compliance. In February 2026, the FDA replaced its Quality System Regulation (QSR) with the Quality Management System Regulation (QMSR), aligning U.S. standards with ISO 13485:2016 [4]. This update means encryption and other security measures are now assessed with the same level of scrutiny as other aspects of medical device compliance. Manufacturers and healthcare organizations must incorporate encryption into their quality management systems from the very beginning, rather than treating it as an afterthought.
The FDA now requires a Secure Product Development Framework (SPDF) to integrate security, including encryption, across the entire product lifecycle. Premarket submissions must include detailed documentation on security boundaries and the mechanisms used to protect data - both in transit and at rest. This marks a shift in how product development and regulatory compliance are approached, emphasizing security as a fundamental component.
FDA Requirements for Labeling and Cybersecurity
Under Section 524B of the FD&C Act, manufacturers are required to provide a Software Bill of Materials (SBOM) in a machine-readable format for all "cyber devices" submitted for premarket approval since March 2023. This SBOM helps healthcare organizations monitor vulnerabilities and manage third-party vendor risk associated with components throughout a device's operational life.
Premarket submissions must also include specifics on encryption methods, certificate provisioning, and lifecycle security controls. Additionally, device labeling must provide users with enough information to securely configure, operate, and decommission devices. This includes details like end-of-support dates, enabling healthcare organizations to plan for replacements and implement compensating controls when necessary.
"A connected device that performs clinically but fails under cybersecurity stress is not meeting intended use expectations in today's regulatory environment." - George Strom, Director, Intertek Connected World [1]
Manufacturers are also required to implement a Vulnerability Management Plan to handle security reports, develop patches, and communicate risks to users throughout the device's lifecycle. These steps ensure ongoing transparency and reinforce the encryption framework, maintaining security oversight over time.
Risk Assessments and Managing Legacy Devices
In addition to labeling and cybersecurity requirements, manufacturers must address the challenges posed by legacy devices. Organizations are now expected to perform annual risk assessments to support encryption strategies and document exceptions for older devices that cannot meet current standards. Legacy devices, particularly those with outdated operating systems, present unique challenges for healthcare organizations.
Devices approved before March 2023 that lack support for AES-256 or TLS 1.2 require compensating controls and a migration plan. Effective compensating controls include:
- Network segmentation: Isolating legacy devices on dedicated virtual networks to separate them from general IT systems.
- Encryption offloading: Using secure gateways to protect data in transit for devices that cannot perform native encryption.
- Enhanced logging and anomaly detection: Monitoring legacy devices for unusual activity to identify potential threats.
These risk assessments should align with both HIPAA risk analysis and FDA cybersecurity risk management (ISO 14971). This alignment reduces redundancy while ensuring data confidentiality and device safety. By uniting quality and security teams under a single framework, organizations can streamline compliance efforts while maintaining the detailed documentation required by regulatory bodies. This approach strengthens cybersecurity and improves the overall safety of medical devices.
Implementation Challenges and Adoption Roadmap
Common Encryption Gaps in Medical Devices
Healthcare organizations face serious medical device security risks when it comes to encryption. A striking 60% of healthcare organizations lack the tools to protect unpatchable devices, and between 50% and 70% are unable to install security agents on these devices [2]. This is particularly alarming as the number of connected medical devices continues to grow across healthcare settings.
Legacy devices are a persistent issue. Updating their firmware to fix encryption vulnerabilities often clashes with regulatory requirements. Since these devices are certified for specific firmware versions under FDA regulations, making unauthorized updates could void their clearances [2]. On top of this, standard cryptographic methods like RSA-2048 and ECDH, commonly used for TLS and API communications, are susceptible to "Harvest Now, Decrypt Later" attacks. In these attacks, encrypted data is recorded today with the intention of decrypting it in the future when quantum computing becomes viable [2].
"Standard IT cryptography falls short - devices require tailored, domain-specific encryption." – Medcrypt [5]
Managing encryption keys adds another layer of complexity. Following NIST SP 800-57 guidelines for key lifecycles - such as rotation schedules and secure storage using Hardware Security Modules (HSMs) - is a considerable technical challenge for many healthcare systems [2]. And with the 2026 HIPAA Security Rule update reclassifying encryption as a required safeguard, organizations can no longer rely on alternative measures to bypass encryption requirements [2].
Given these challenges, a structured roadmap is essential to close encryption gaps while maintaining compliance and operational efficiency.
Step-by-Step Encryption Implementation Plan
Tackling encryption gaps calls for a phased and methodical approach to avoid disrupting clinical workflows while meeting regulatory standards. The process should start with a thorough inventory of electronic Protected Health Information (ePHI). This inventory should map every system, database, API, and backup that stores or transmits ePHI [3]. Identifying these areas is a critical first step for pinpointing vulnerabilities and determining which devices need compensating controls.
To align with updated FDA and HIPAA regulations, organizations should focus on quick wins first, followed by more complex solutions. Begin by enabling AES-256 encryption for data at rest. Tools like BitLocker or LUKS can secure workstations, while Transparent Data Encryption (TDE) can protect backend databases [3]. Next, enforce TLS 1.2 or higher for all network transmissions, and disable older protocols like TLS 1.0 and 1.1 that no longer meet compliance standards [3]. For devices without native encryption capabilities, consider network segmentation or secure gateway offloading as alternatives [2].
For advanced protection, extend encryption to specific application fields to safeguard sensitive PHI such as names, Social Security numbers, and medical diagnoses. This helps mitigate risks from SQL injection and insider threats [3]. Establish a robust key lifecycle management process, including regular key rotation and secure storage in HSMs, as outlined in NIST SP 800-57 [3]. To prepare for quantum computing threats, implement quantum-safe key exchanges like Kyber-1024 and audit signatures such as Dilithium-5 for data requiring long-term protection (6–30 years) [3].
Collaboration with device manufacturers is critical throughout this process. Moving from shared keys to unique keys for each device and function ensures that a single breach doesn’t compromise an entire product line [5]. Secure firmware signing, trusted boot protocols, and anti-replay mechanisms are also essential to ensure devices only execute authorized, encrypted updates [5]. This collaborative strategy ensures compliance with FDA cybersecurity guidance and HIPAA requirements while maintaining device functionality and patient safety.
Managing Encryption Compliance with Censinet RiskOps™
To tackle the strict encryption standards coming in 2026, healthcare organizations are turning to integrated tools like Censinet RiskOps™.
Automated Risk Assessments and Compliance Reporting
Staying compliant with 2026 encryption standards means healthcare providers must keep a constant eye on countless medical devices and third-party vendors. Censinet RiskOps™ simplifies this by automating the process. It scans vendor questionnaires to check if devices meet encryption standards like AES-256 for stored data and TLS 1.3 for transmitted data. Using templates aligned with FDA guidelines, it flags issues such as weak key management - a problem seen in 70% of older IoMT devices.
The platform also provides real-time dashboards and audit-ready reports that map encryption practices to FDA cybersecurity labeling requirements. For example, it automates evidence collection for TLS 1.3 compliance. One healthcare delivery organization cut reporting time by 60% when assessing over 500 vendors. Users reported 50–75% faster third-party assessments and a 40% boost in overall cyber risk scores. Another organization pinpointed encryption vulnerabilities in 40% of connected infusion pumps, allowing them to address issues before FDA audits. Meanwhile, one HDO achieved 95% compliance with 2026 standards across 200 devices, as verified by independent audits [6]. These insights streamline collaboration between healthcare providers and vendors, making compliance efforts more efficient.
Enhancing Collaboration Between Healthcare Organizations and Vendors
Fixing encryption gaps is an ongoing effort that requires close teamwork between healthcare providers and device manufacturers. Censinet RiskOps™ supports this with a collaborative portal where healthcare organizations can share encrypted risk assessment results with vendors in real time, enabling quicker action plans.
The platform includes a remediation workflow that identifies outdated devices through inventory integration, assigns encryption scores, and sends collaboration requests to vendors. It also tracks upgrades. For instance, one vendor updated firmware to support TLS 1.3 within 30 days of being notified. In a pilot program, this workflow helped reduce non-compliant devices by 85% in six months. The system integrates with tools like EHRs and MDM systems to monitor encryption metrics, send alerts for expiring TLS certificates, and automate quarterly FDA surveillance reports [6].
Conclusion
The 2026 encryption standards represent a major shift in securing medical devices. Under the updated HIPAA Security Rule, encryption is now mandatory, requiring AES-256 for stored data and TLS 1.2 or higher for transmitted data across all electronic protected health information (ePHI). This comes at a time when 60% of healthcare organizations have reported persistent vulnerabilities. With the Internet of Medical Things market expected to hit $650 billion by 2030, these changes couldn’t come at a more pressing time [2].
The new mandates also introduce stricter safeguards. Business associates must now report security incidents within 24 hours instead of the previous 60-day window. Additionally, multi-factor authentication (MFA) is required for all ePHI access, and network segmentation must be employed to isolate medical device communications. Noncompliance carries steep penalties, with Tier 4 HIPAA violations (willful neglect without correction) resulting in fines of up to $1,500,000 annually. These measures are essential for both protecting patients and maintaining financial stability [2].
Given the complexity of managing hundreds of medical devices and vendor relationships, healthcare organizations need automated solutions to stay compliant. Tools like Censinet RiskOps™ simplify risk assessments and monitor encryption compliance across devices and vendors. Its collaborative platform allows real-time remediation workflows, helping organizations meet the updated standards with greater efficiency.
With final rules anticipated by May 2026, healthcare providers must act swiftly. Updating device inventories, revising Business Associate Agreements to reflect the 24-hour notification rule, and implementing compensating controls for outdated systems are critical steps. These efforts not only safeguard patient data but also ensure that healthcare organizations remain viable in an increasingly interconnected ecosystem.
FAQs
What medical device data must be encrypted under the 2026 HIPAA update?
Starting in 2026, the HIPAA update mandates that all electronic protected health information (ePHI) must be encrypted when stored, transmitted, or accessed remotely. This means healthcare organizations and their partners need to adopt specific encryption standards to safeguard patient data.
For data at rest, Advanced Encryption Standard (AES-256) is required. This level of encryption ensures that stored information remains secure from unauthorized access. For data in transit, protocols like TLS 1.2 or higher must be used to protect information as it moves across networks.
By implementing these encryption measures, organizations can meet compliance requirements and better protect sensitive patient information from potential breaches.
How can we secure legacy devices that can’t support AES-256 or TLS 1.2+?
Securing older devices that don't support AES-256 or TLS 1.2+ requires a focused approach. Key measures include network segmentation to isolate these vulnerable devices, planning for replacement or secure decommissioning of outdated equipment, and conducting regular risk assessments to uncover and address potential weaknesses. These strategies help minimize the risks tied to outdated medical devices.
What key management practices are required for AES-256 and TLS in healthcare?
Managing keys for AES-256 and TLS in the healthcare sector requires a strong focus on security and compliance. Here’s what it involves:
- Secure Key Generation: Generate encryption keys using trusted algorithms and secure environments to prevent unauthorized access.
- Proper Storage: Store keys securely using hardware security modules (HSMs) or cloud-based key management systems. These solutions provide enhanced protection against breaches.
- Regular Rotation: Rotate keys periodically, such as every 90 days, to minimize risks associated with potential key compromise.
Additionally, enforce role-based access control to limit who can access or manage encryption keys. Combine this with multi-factor authentication to add an extra layer of security. These practices help ensure both compliance with healthcare regulations and the protection of sensitive patient data.
